Showing results (211-220 of 1,150) with videos related to
Sort By:
Pageof 115
Brain, Behavior, & Immunity - Health|February 20, 2024
Retinal-glia ischemia and inflammation induced by chronic stress: The SABPA studyLeoné Malan, Mark Hamer, Roland von Känel, et al.Brain, Behavior, & Immunity - Health|February 20, 2024
Adverse childhood experiences and biomarkers of inflammation in a diverse cohort of early school-aged childrenNia Heard-Garris, Matthew M Davis, Ryne Estabrook, et al.Brain, Behavior, & Immunity - Health|February 20, 2024
Whole body vibration elicits differential immune and metabolic responses in obese and normal weight individualsAnson M Blanks, Paula Rodriguez-Miguelez, Jacob Looney, et al.Brain, Behavior, & Immunity - Health|February 20, 2024
Acute exercise decreases vaccine reactions following influenza vaccination among older adultsErika Bohn-Goldbaum, April Pascoe, Maria Fiatarone Singh, et al.Brain, Behavior, & Immunity - Health|February 20, 2024
Patients with ME/CFS (Myalgic Encephalomyelitis/Chronic Fatigue Syndrome) and chronic pain report similar level of sickness behavior as individuals injected with bacterial endotoxin at peak inflammationMartin A Jonsjö, Jenny Åström, Michael P Jones, et al.Brain, Behavior, & Immunity - Health|February 20, 2024
Alcohol induced NLRP3 inflammasome activation in the brain of rats is attenuated by ATRA supplementationS H Priyanka, A J Thushara, Arun A Rauf, et al.Brain, Behavior, & Immunity - Health|February 20, 2024
The origin and nature of the complex autoantibody profile in cerebrospinal fluidRahil Kheirkhah, Cassandra DeMarshall, Frederick Sieber, et al.Brain, Behavior, & Immunity - Health|March 4, 2024
Neuroimmune modulators as novel pharmacotherapies for substance use disordersErica N GrodinBrain, Behavior, & Immunity - Health|February 16, 2024
Neutrophil-to-lymphocyte ratio as a predictive biomarker for early diagnosis of depression: A narrative reviewSayed Soran Ghafori, Zahra Yousefi, Elham Bakhtiari, et al.Brain, Behavior, & Immunity - Health|February 14, 2024
Low-dose naltrexone and NAD+ for the treatment of patients with persistent fatigue symptoms after COVID-19Anar Isman, Andy Nyquist, Bailey Strecker, et al.Pageof 115